Andrey V. Markov

499 total citations
41 papers, 392 citations indexed

About

Andrey V. Markov is a scholar working on Molecular Biology, Pharmacology and Immunology. According to data from OpenAlex, Andrey V. Markov has authored 41 papers receiving a total of 392 indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Molecular Biology, 13 papers in Pharmacology and 8 papers in Immunology. Recurrent topics in Andrey V. Markov's work include Natural product bioactivities and synthesis (14 papers), Pharmacological Effects of Natural Compounds (13 papers) and Bioactive Compounds and Antitumor Agents (5 papers). Andrey V. Markov is often cited by papers focused on Natural product bioactivities and synthesis (14 papers), Pharmacological Effects of Natural Compounds (13 papers) and Bioactive Compounds and Antitumor Agents (5 papers). Andrey V. Markov collaborates with scholars based in Russia, Egypt and Poland. Andrey V. Markov's co-authors include Marina A. Zenkova, Нариман Ф. Салахутдинов, Oksana V. Salomatina, Aleksandra V. Sen’kova, Innokenty A. Savin, Valentin V. Vlassov, Д. В. Корчагина, Genrikh A. Tolstikov, Dawid Warszycki and Аndrey V. Shernyukov and has published in prestigious journals such as PLoS ONE, Scientific Reports and International Journal of Molecular Sciences.

In The Last Decade

Andrey V. Markov

37 papers receiving 383 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Andrey V. Markov Russia 12 231 136 54 48 46 41 392
Yung-Ting Hsiao Taiwan 14 244 1.1× 47 0.3× 37 0.7× 70 1.5× 23 0.5× 15 387
Zhaoning Ji China 14 309 1.3× 92 0.7× 19 0.4× 40 0.8× 45 1.0× 21 438
Weitian Wei China 8 170 0.7× 43 0.3× 34 0.6× 54 1.1× 45 1.0× 11 389
MyongHak Ri China 11 230 1.0× 75 0.6× 77 1.4× 89 1.9× 39 0.8× 12 447
Chung-Hang Leung United States 9 275 1.2× 76 0.6× 26 0.5× 44 0.9× 43 0.9× 12 406
Shih‐Chung Hsu Taiwan 11 178 0.8× 53 0.4× 34 0.6× 76 1.6× 69 1.5× 16 364
Vijay J. Raja United States 9 187 0.8× 72 0.5× 35 0.6× 25 0.5× 64 1.4× 14 330
Lingyuan Xu China 9 180 0.8× 44 0.3× 40 0.7× 49 1.0× 46 1.0× 11 397
Zhongwen Luo China 10 267 1.2× 40 0.3× 39 0.7× 41 0.9× 42 0.9× 24 403
Jun‐Kui Li Hong Kong 11 170 0.7× 43 0.3× 55 1.0× 42 0.9× 17 0.4× 16 334

Countries citing papers authored by Andrey V. Markov

Since Specialization
Citations

This map shows the geographic impact of Andrey V. Markov's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrey V. Markov with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrey V. Markov more than expected).

Fields of papers citing papers by Andrey V. Markov

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andrey V. Markov. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrey V. Markov. The network helps show where Andrey V. Markov may publish in the future.

Co-authorship network of co-authors of Andrey V. Markov

This figure shows the co-authorship network connecting the top 25 collaborators of Andrey V. Markov. A scholar is included among the top collaborators of Andrey V. Markov based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andrey V. Markov. Andrey V. Markov is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Rybalova, Tatyana V., et al.. (2025). Synthesis and exploration of anticancer potential of spirocyclic 1,2,3-triazoline and aziridine derivatives of natural eudesmanolide isoalantolactone. Bioorganic Chemistry. 155. 108124–108124. 1 indexed citations
2.
Мирошниченко, С. К., Olga Patutina, Andrey V. Markov, et al.. (2025). Biological Performance and Molecular Mechanisms of Mesyl MicroRNA-Targeted Oligonucleotides in Colorectal Cancer Cells. International Journal of Molecular Sciences. 26(23). 11747–11747.
3.
Sen’kova, Aleksandra V., Oksana V. Salomatina, Oleg V. Markov, et al.. (2024). Soloxolone para-methylanilide effectively suppresses aggressive phenotype of glioblastoma cells including TGF-β1-induced glial-mesenchymal transition in vitro and inhibits growth of U87 glioblastoma xenografts in mice. Frontiers in Pharmacology. 15. 1428924–1428924. 2 indexed citations
4.
Zenkova, Marina A., et al.. (2023). The Nexus of Inflammation-Induced Epithelial-Mesenchymal Transition and Lung Cancer Progression: A Roadmap to Pentacyclic Triterpenoid-Based Therapies. International Journal of Molecular Sciences. 24(24). 17325–17325. 10 indexed citations
5.
6.
Markov, Andrey V., et al.. (2023). Evaluation of the Antitumor Potential of Soloxolone Tryptamide against Glioblastoma Multiforme Using in silico, in vitro, and in vivo Approaches. Biochemistry (Moscow). 88(7). 1008–1021. 5 indexed citations
7.
Markov, Andrey V., Innokenty A. Savin, Marina A. Zenkova, & Aleksandra V. Sen’kova. (2023). Identification of Novel Core Genes Involved in Malignant Transformation of Inflamed Colon Tissue Using a Computational Biology Approach and Verification in Murine Models. International Journal of Molecular Sciences. 24(5). 4311–4311. 5 indexed citations
8.
Chernikov, Ivan V., Aleksandra V. Sen’kova, Innokenty A. Savin, et al.. (2023). siRNA-Mediated Timp1 Silencing Inhibited the Inflammatory Phenotype during Acute Lung Injury. International Journal of Molecular Sciences. 24(2). 1641–1641. 9 indexed citations
9.
10.
Sen’kova, Aleksandra V., Innokenty A. Savin, Oksana V. Salomatina, et al.. (2023). Protective effect of soloxolone derivatives in carrageenan- and LPS-driven acute inflammation: Pharmacological profiling and their effects on key inflammation-related processes. Biomedicine & Pharmacotherapy. 159. 114231–114231. 6 indexed citations
11.
Salomatina, Oksana V., Aleksandra V. Sen’kova, Innokenty A. Savin, et al.. (2022). Novel Epoxides of Soloxolone Methyl: An Effect of the Formation of Oxirane Ring and Stereoisomerism on Cytotoxic Profile, Anti-Metastatic and Anti-Inflammatory Activities In Vitro and In Vivo. International Journal of Molecular Sciences. 23(11). 6214–6214. 10 indexed citations
12.
Мирошниченко, С. К., Olga Patutina, Aleksandra V. Sen’kova, et al.. (2022). Single Shot vs. Cocktail: A Comparison of Mono- and Combinative Application of miRNA-Targeted Mesyl Oligonucleotides for Efficient Antitumor Therapy. Cancers. 14(18). 4396–4396. 14 indexed citations
13.
Sen’kova, Aleksandra V., Oleg V. Markov, Andrey V. Markov, et al.. (2022). Bovine Pancreatic RNase A: An Insight into the Mechanism of Antitumor Activity In Vitro and In Vivo. Pharmaceutics. 14(6). 1173–1173. 1 indexed citations
14.
Savin, Innokenty A., Andrey V. Markov, Marina A. Zenkova, & Aleksandra V. Sen’kova. (2022). Asthma and Post-Asthmatic Fibrosis: A Search for New Promising Molecular Markers of Transition from Acute Inflammation to Pulmonary Fibrosis. Biomedicines. 10(5). 1017–1017. 12 indexed citations
15.
Sen’kova, Aleksandra V., et al.. (2021). Core genes involved in the regulation of acute lung injury and their association with COVID-19 and tumor progression: A bioinformatics and experimental study. PLoS ONE. 16(11). e0260450–e0260450. 10 indexed citations
16.
Markov, Andrey V., et al.. (2021). Uncovering the anti-angiogenic effect of semisynthetic triterpenoid CDDO-Im on HUVECs by an integrated network pharmacology approach. Computers in Biology and Medicine. 141. 105034–105034. 9 indexed citations
17.
18.
Ogienko, Andrey G., Andrey V. Markov, Aleksandra V. Sen’kova, et al.. (2018). Increasing bioavailability of very poorly water-soluble compounds. A case study of an anti-tumor drug, soloxolon methyl. Journal of Drug Delivery Science and Technology. 49. 35–42. 6 indexed citations
19.
20.
Salomatina, Oksana V., Andrey V. Markov, Д. В. Корчагина, et al.. (2013). Synthesis of novel 2-cyano substituted glycyrrhetinic acid derivatives as inhibitors of cancer cells growth and NO production in LPS-activated J-774 cells. Bioorganic & Medicinal Chemistry. 22(1). 585–593. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yung-Ting Hsiao Breakdown of academic impact, for papers by Zhaoning Ji Breakdown of academic impact, for papers by Weitian Wei Breakdown of academic impact, for papers by MyongHak Ri Breakdown of academic impact, for papers by Chung-Hang Leung Breakdown of academic impact, for papers by Shih‐Chung Hsu Breakdown of academic impact, for papers by Vijay J. Raja Breakdown of academic impact, for papers by Lingyuan Xu Breakdown of academic impact, for papers by Zhongwen Luo Breakdown of academic impact, for papers by Jun‐Kui Li
Rankless by CCL
2026